Showing results (21-30 of 140) with videos related to
Sort By:
Pageof 14
Experimental Hematology & Oncology|January 30, 2016
Identification of AIM2 as a downstream target of JAK2V617FEi Leen Liew, Marito Araki, Yumi Hironaka, et al.Oncotarget|March 28, 2018
RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancerMadhura Kulkarni, Tuan Zea Tan, Nurfarhanah Bte Syed Sulaiman, et al.International Journal of Biological Sciences|November 22, 2021
MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathwaysJianzhou Cui, Yi Yuan, Muthu K Shanmugam, et al.Cancer Research|February 19, 2021
SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple MyelomaPhyllis S Y Chong, Jing Yuan Chooi, Julia S L Lim, et al.Nature Cell Biology|July 7, 2014
Lgr5 marks stem/progenitor cells in ovary and tubal epitheliaAnnie Ng, Shawna Tan, Gurmit Singh, et al.Human Pathology|December 3, 2014
The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusionsBen Davidson, Arild Holth, Ellen Hellesylt, et al.Prenatal Diagnosis|November 18, 2014
Non-invasive prenatal diagnostic testing for β-thalassaemia using cell-free fetal DNA and next generation sequencingLi Xiong, Angela N Barrett, Rui Hua, et al.Oncoimmunology|February 16, 2017
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200Muhammad Zaeem Noman, Bassam Janji, Abderemane Abdou, et al.Oncotarget|November 10, 2015
CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtypeTuan Zea Tan, He Yang, Jieru Ye, et al.Ebiomedicine|November 26, 2019
Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypesTuan Zea Tan, Jieru Ye, Chung Vin Yee, et al.Pageof 14